Literature DB >> 19605645

Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

Qiu-Lan Ma1, Fusheng Yang, Emily R Rosario, Oliver J Ubeda, Walter Beech, Dana J Gant, Ping Ping Chen, Beverly Hudspeth, Cory Chen, Yongle Zhao, Harry V Vinters, Sally A Frautschy, Greg M Cole.   

Abstract

Both insulin resistance (type II diabetes) and beta-amyloid (Abeta) oligomers are implicated in Alzheimer's disease (AD). Here, we investigate the role of Abeta oligomer-induced c-Jun N-terminal kinase (JNK) activation leading to phosphorylation and degradation of the adaptor protein insulin receptor substrate-1 (IRS-1). IRS-1 couples insulin and other trophic factor receptors to downstream kinases and neuroprotective signaling. Increased phospho-IRS-1 is found in AD brain and insulin-resistant tissues from diabetics. Here, we report Abeta oligomers significantly increased active JNK and phosphorylation of IRS-1 (Ser616) and tau (Ser422) in cultured hippocampal neurons, whereas JNK inhibition blocked these responses. The omega-3 fatty acid docosahexaenoic acid (DHA) similarly inhibited JNK and the phosphorylation of IRS-1 and tau in cultured hippocampal neurons. Feeding 3xTg-AD transgenic mice a diet high in saturated and omega-6 fat increased active JNK and phosphorylated IRS-1 and tau. Treatment of the 3xTg-AD mice on high-fat diet with fish oil or curcumin or a combination of both for 4 months reduced phosphorylated JNK, IRS-1, and tau and prevented the degradation of total IRS-1. This was accompanied by improvement in Y-maze performance. Mice fed with fish oil and curcumin for 1 month had more significant effects on Y-maze, and the combination showed more significant inhibition of JNK, IRS-1, and tau phosphorylation. These data indicate JNK mediates Abeta oligomer inactivation of IRS-1 and phospho-tau pathology and that dietary treatment with fish oil/DHA, curcumin, or a combination of both has the potential to improve insulin/trophic signaling and cognitive deficits in AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19605645      PMCID: PMC3849615          DOI: 10.1523/JNEUROSCI.1071-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  98 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 2.  The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory.

Authors:  Robert N Hughes
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

3.  Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway.

Authors:  X J Sun; J L Goldberg; L Y Qiao; J J Mitchell
Journal:  Diabetes       Date:  1999-07       Impact factor: 9.461

4.  Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

Authors:  Pascale N Lacor; Maria C Buniel; Lei Chang; Sara J Fernandez; Yuesong Gong; Kirsten L Viola; Mary P Lambert; Pauline T Velasco; Eileen H Bigio; Caleb E Finch; Grant A Krafft; William L Klein
Journal:  J Neurosci       Date:  2004-11-10       Impact factor: 6.167

5.  Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.

Authors:  B Puig; T Gómez-Isla; E Ribé; M Cuadrado; B Torrejón-Escribano; E Dalfó; I Ferrer
Journal:  Neuropathol Appl Neurobiol       Date:  2004-10       Impact factor: 8.090

6.  Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.

Authors:  Frédéric Calon; Giselle P Lim; Fusheng Yang; Takashi Morihara; Bruce Teter; Oliver Ubeda; Phillippe Rostaing; Antoine Triller; Norman Salem; Karen H Ashe; Sally A Frautschy; Greg M Cole
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

7.  Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.

Authors:  Zhanguo Gao; Xiaoying Zhang; Aamir Zuberi; Daniel Hwang; Michael J Quon; Michael Lefevre; Jianping Ye
Journal:  Mol Endocrinol       Date:  2004-05-13

Review 8.  N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?

Authors:  Jacques Delarue; Christelle LeFoll; Charlotte Corporeau; Danièle Lucas
Journal:  Reprod Nutr Dev       Date:  2004 May-Jun

9.  Structural differences between insulin receptors in the brain and peripheral target tissues.

Authors:  K A Heidenreich; N R Zahniser; P Berhanu; D Brandenburg; J M Olefsky
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

10.  Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.

Authors:  Francesco Andreozzi; Emanuela Laratta; Angela Sciacqua; Francesco Perticone; Giorgio Sesti
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367

View more
  184 in total

Review 1.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

Review 2.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

Review 3.  Collaborative effects of diet and exercise on cognitive enhancement.

Authors:  Fernando Gomez-Pinilla
Journal:  Nutr Health       Date:  2011

4.  Alzheimer disease: Insulin resistance and AD--extending the translational path.

Authors:  Suzanne Craft
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

Review 5.  Current therapeutic targets for the treatment of Alzheimer's disease.

Authors:  Joshua D Grill; Jeffrey L Cummings
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 6.  Dietary fatty acids and the aging brain.

Authors:  Greg M Cole; Qiu-Lan Ma; Sally A Frautschy
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 7.  Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Santosh Kumar Tota; Ashok Kumar; Abdullah S Ahmad
Journal:  Mol Neurobiol       Date:  2015-08-23       Impact factor: 5.590

Review 8.  The neurodegeneration in Alzheimer disease and the prion protein.

Authors:  Gianluigi Forloni; Alessandra Sclip; Tiziana Borsello; Claudia Balducci
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 9.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

Review 10.  Cellular membrane fluidity in amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Grace Y Sun; Gunter P Eckert; James C-M Lee
Journal:  Mol Neurobiol       Date:  2014-02-20       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.